Equine Serum Market By Formulation Type (Heat Inactivated, Non Heat Inactivated, Customized Formulations, and Others); By Packaging Size (100 ml, 500 ml, 1000 ml, Custom Packaging, and Others); By Application (Diagnostic Assay, Vaccine Production for Humans and Animals, Supplement in Bacteriological Media, and Others); By End Users (Research Institutions and Pharmaceutical Manufacturing Companies); By Distribution Channels (Online and Offline); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Equine serum is defined as blood serum derived from horse. Different types of equine serum contain monoclonal antibodies or polyclonal antibodies. These antibodies can spread passive immunity to prevent many diseases via blood donation (plasmaphoresis). For example, transfusion of a passive antibody called convalescent serum from a previous human survivor was considered to be the only known effective treatment for ebola infection with a high success rate where 7 out of 8 patients survived.
Many factors are driving the global equine serum market but the most important factors are increasing adoption of organic farming among farmers and advancements in integrated pest management solutions. Modern crop protection products are being used continuously and extensively to eliminate or reduce pest infestation. Hence, pests have developed resistance to conventional crop protection products. Along with fetal bovine serum (FBS), equine serum is also being used as an important source of nutrients for in vitro cell growth. High cost associated with the manufacturing and storage of equine serum is impeding the growth of global equine serum market. Keeping the serum under certain kind of temperature to avoid contamination is essential. Storage of serum during its transfer from manufacturers to research institutions (pharmaceutical manufacturing companies) is also necessary.
The attempts to develop vaccine that can prevent COVID-19, along with medicines that might cure the virus infection using equine serum showcases significant growth opportunities for the global equine serum market over the forecast period. Biological E and Indian Council of Medical Research (ICMR) are working together to develop horse antiserum for coronavirus treatment. After obtaining permission from them, if other pharmaceutical companies, which are working to manufacture medicine or vaccine for COVID-19 treatment or prevention, a new opportunity can rise in medicine market. In a study, recombinant human monoclonal antibody (RBD)-specific polyclonal F(ab)2 fragments of equine antibodies had positive impact on patients who had moderate or severe COVID-19 disease. Results from 19 hospitals in Argentina were compiled to draw this results. Hence, group of equine poly-clonal antibodies (EpAbs) called INM005 was found to be safe for COVID treatment.
Absolute Market Insights reports, the global equine serum market is likely to grow at 5.8% CAGR during the 2021-2029 period, and reach a valuation of US$ 63.65 Mn by 2029.
Equine Serum Market Revenue & Forecast, (US$ Million), 2015 – 2029
Formulation Type Outlook:
By formulation type, this research report from Absolute Markets Insights on global equine serum market covers heat inactivated, non-heat inactivated, customized formulations, and others. During the forecast period, customized formulations segment is estimated to register substantial growth rate in the market. Through customization, arrangements can be made for temperature related compulsions and there can be more liberty regarding storage. For example, if there is a formula that has to be stored in a cold storage with 10 degree temperature, the customization of that formula may remove this compulsion and storing that formula in normal temperature may not contaminate it. Some serums require storage with certain temperature but this is not always an issue with customized formulations.
Packaging Size Outlook:
The packaging size segment in the global equine serum market is classified on the basis of 100 millilitres (ml) pack, 500 ml pack, 1000 ml pack, custom packaging, and others. Custom packaging category is gaining traction in the global equine serum market owing to different requirements, storage limitations, and need for specific quantities. Occasionally, doctors manufacturing equine serum plan customized packages as per the requirements of clients seeking to buy equine serum. Packages made as per the specifications requested by clients are among the new trends in the world of packaging.
Application Outlook:
The application segment of the global equine serum market in this report has been broadly segmented into diagnostic assay, vaccine production for humans & animals, supplement in bacteriological media, and others. The vaccine production for humans and animals segment is anticipated to witness highest CAGR over the period of next eight years. Equine serum is being increasingly used for experiments meant to develop vaccines. Serum being drawn from a horse was used for manufacturing vaccines and medicines to cure diphtheria toxin in 1895 and later to cure scarlet fever and tetanus. Search for new vaccines is being carried out due to COVID-19 and experiments for the same are being done with equine serum by scientists in many countries.
Distribution Channel Outlook:
The global equine serum market report segments the distribution channel segment into online distribution channels and offline distribution channels. Online distribution channels are gaining popularity across research centres and pharmaceutical manufacturers, who are increasingly relying on online channels for ordering their requisite package. Hence, many serum manufactures who deal with horses and collect their blood samples have started selling their products online.
End User Outlook:
Based on end users, this report from Absolute Markets Insights segments the global equine serum market into research institutions and pharmaceutical manufacturing companies. In 2020, research institutions segment occupied larger market share. During the forecast period, intensified demand for equine serum is anticipated to be generated from the pharmaceutical manufacturing companies. The initiatives and investments being directed by these companies towards the development of vaccines at large is expected to influence the segment’s growth over the forecast period.
Region Outlook:
In 2020, North America had the largest market share in the global equine serum market. During the forecast period, Asia Pacific region is expected to witness highest growth rate due to increasing awareness about equine serum and more research operations about exploring its use for manufacturing medicines and attempts to use it for making vaccines. Increasing healthcare expenditure along with rise in the budgetary allocation by governments in Asian countries is furthering the region’s growth in the global market.
Competitive Landscape Outlook:
The global equine serum market landscape remains a highly innovative, competitive, and fragmented. Despite major investments from many big players of medical sector enterprises, most companies do not have a sizable share of the market to influence pricing. Furthermore, the barriers to entry are financial and technological (regarding refrigeration and storage) in nature. Some key players in the global equine serum equine serum market are Abcam PLC, Biochemed Services, Biologos, Capricorn Scientific GmbH, Jackson ImmunoResearch Inc., Merck KGaA, MP BIOMEDICALS, Rocky Mountain Biologicals, TCS Biosciences Ltd., and Thermo Fisher Scientific Inc amongst others.
Global Equine Serum Market:
- By Formulation Type
- Heat Inactivated
- Non Heat Inactivated
- Customized Formulations
- Others
- By Application
- Diagnostic Assay
- Vaccine Production for Humans and Animals
- Supplement in Bacteriological Media
- Others
- By Packaging Size
- 100 ml
- 500 ml
- 1000 ml
- Custom Packaging
- Others
- By End Users
- Research Institutions
- Pharmaceutical Manufacturing Companies
- By Distribution Channel
- Online
- Offline
- By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market
Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from RNR’s Perspective**
5. Holistic Overview of Equine Serum Market
6. Market Synopsis:
Equine Serum Market
7. Equine Serum Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Equine Serum Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Equine Serum Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Equine Serum Market
8. Global Equine Serum Market Analysis and Forecasts, 2021 –
2029
8.1. Overview
8.1.1. Global Equine Serum Market Revenue (US$ Mn)
8.2. Global
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Formulation Type
8.2.1. Heat Inactivated
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 – 2020
8.2.1.3. Market Forecast, 2021 – 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 – 2020
8.2.1.5.1.2. Market
Forecast, 2021 – 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2020
8.2.1.5.2.2. Market
Forecast, 2021 – 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2020
8.2.1.5.3.2. Market
Forecast, 2021 – 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2020
8.2.1.5.4.2. Market
Forecast, 2021 – 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 – 2020
8.2.1.5.5.2. Market
Forecast, 2021 – 2029
8.2.2. Non Heat Inactivated
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 – 2020
8.2.2.3. Market Forecast, 2021 – 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 – 2020
8.2.2.5.1.2. Market
Forecast, 2021 – 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2020
8.2.2.5.2.2. Market
Forecast, 2021 – 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2020
8.2.2.5.3.2. Market
Forecast, 2021 – 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2020
8.2.2.5.4.2. Market
Forecast, 2021 – 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 – 2020
8.2.2.5.5.2. Market
Forecast, 2021 – 2029
8.2.3. Customized Formulations
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 – 2020
8.2.3.3. Market Forecast, 2021 – 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 – 2020
8.2.3.5.1.2. Market
Forecast, 2021 – 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2020
8.2.3.5.2.2. Market
Forecast, 2021 – 2029
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2020
8.2.3.5.3.2. Market
Forecast, 2021 – 2029
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2020
8.2.3.5.4.2. Market
Forecast, 2021 – 2029
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 – 2020
8.2.3.5.5.2. Market
Forecast, 2021 – 2029
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 – 2020
8.2.4.3. Market Forecast, 2021 – 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 – 2020
8.2.4.5.1.2. Market
Forecast, 2021 – 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2020
8.2.4.5.2.2. Market
Forecast, 2021 – 2029
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2020
8.2.4.5.3.2. Market
Forecast, 2021 – 2029
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2020
8.2.4.5.4.2. Market
Forecast, 2021 – 2029
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 – 2020
8.2.4.5.5.2. Market
Forecast, 2021 – 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By Formulation Type
9. Global Equine Serum Market Analysis and Forecasts, 2021 –
2029
9.1. Overview
9.2. Global
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Diagnostic Assay
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 – 2020
9.2.1.3. Market Forecast, 2021 – 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 – 2020
9.2.1.5.1.2. Market
Forecast, 2021 – 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2020
9.2.1.5.2.2. Market
Forecast, 2021 – 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2020
9.2.1.5.3.2. Market
Forecast, 2021 – 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2020
9.2.1.5.4.2. Market
Forecast, 2021 – 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 – 2020
9.2.1.5.5.2. Market
Forecast, 2021 – 2029
9.2.2. Vaccine Production for Humans and Animals
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 – 2020
9.2.2.3. Market Forecast, 2021 – 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 – 2020
9.2.2.5.1.2. Market
Forecast, 2021 – 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2020
9.2.2.5.2.2. Market
Forecast, 2021 – 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2020
9.2.2.5.3.2. Market
Forecast, 2021 – 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2020
9.2.2.5.4.2. Market
Forecast, 2021 – 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 – 2020
9.2.2.5.5.2. Market
Forecast, 2021 – 2029
9.2.3. Supplement in Bacteriological Media
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 – 2020
9.2.3.3. Market Forecast, 2021 – 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 – 2020
9.2.3.5.1.2. Market
Forecast, 2021 – 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2020
9.2.3.5.2.2. Market
Forecast, 2021 – 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2020
9.2.3.5.3.2. Market
Forecast, 2021 – 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2020
9.2.3.5.4.2. Market
Forecast, 2021 – 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 – 2020
9.2.3.5.5.2. Market
Forecast, 2021 – 2029
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 – 2020
9.2.4.3. Market Forecast, 2021 – 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 – 2020
9.2.4.5.1.2. Market
Forecast, 2021 – 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2020
9.2.4.5.2.2. Market
Forecast, 2021 – 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2020
9.2.4.5.3.2. Market
Forecast, 2021 – 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2020
9.2.4.5.4.2. Market
Forecast, 2021 – 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 – 2020
9.2.4.5.5.2. Market
Forecast, 2021 – 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By Application
10. Global Equine Serum Market Analysis and Forecasts, 2021 –
2029
10.1. Overview
10.2. Global
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Packaging Size
10.2.1. 100 ml
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 – 2020
10.2.1.3. Market Forecast, 2021 – 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 – 2020
10.2.1.5.1.2. Market
Forecast, 2021 – 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2020
10.2.1.5.2.2. Market
Forecast, 2021 – 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2020
10.2.1.5.3.2. Market
Forecast, 2021 – 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2020
10.2.1.5.4.2. Market
Forecast, 2021 – 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 – 2020
10.2.1.5.5.2. Market
Forecast, 2021 – 2029
10.2.2. 500 ml
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 – 2020
10.2.2.3. Market Forecast, 2021 – 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 – 2020
10.2.2.5.1.2. Market
Forecast, 2021 – 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2020
10.2.2.5.2.2. Market
Forecast, 2021 – 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2020
10.2.2.5.3.2. Market
Forecast, 2021 – 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2020
10.2.2.5.4.2. Market
Forecast, 2021 – 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 – 2020
10.2.2.5.5.2. Market
Forecast, 2021 – 2029
10.2.3. 1000 ml
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 – 2020
10.2.3.3. Market Forecast, 2021 – 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 – 2020
10.2.3.5.1.2. Market
Forecast, 2021 – 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2020
10.2.3.5.2.2. Market
Forecast, 2021 – 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2020
10.2.3.5.3.2. Market
Forecast, 2021 – 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2020
10.2.3.5.4.2. Market
Forecast, 2021 – 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 – 2020
10.2.3.5.5.2. Market
Forecast, 2021 – 2029
10.2.4. Custom Packaging
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 – 2020
10.2.4.3. Market Forecast, 2021 – 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 – 2020
10.2.4.5.1.2. Market
Forecast, 2021 – 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2020
10.2.4.5.2.2. Market
Forecast, 2021 – 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2020
10.2.4.5.3.2. Market
Forecast, 2021 – 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2020
10.2.4.5.4.2. Market
Forecast, 2021 – 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 – 2020
10.2.4.5.5.2. Market
Forecast, 2021 – 2029
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 – 2020
10.2.5.3. Market Forecast, 2021 – 2029
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 – 2020
10.2.5.5.1.2. Market
Forecast, 2021 – 2029
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 – 2020
10.2.5.5.2.2. Market
Forecast, 2021 – 2029
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 – 2020
10.2.5.5.3.2. Market
Forecast, 2021 – 2029
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 – 2020
10.2.5.5.4.2. Market
Forecast, 2021 – 2029
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 – 2020
10.2.5.5.5.2. Market
Forecast, 2021 – 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By Packaging Size
11. Global Equine Serum Market Analysis and Forecasts, 2021 –
2029
11.1. Overview
11.2. Global
Equine Serum Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Research Institutions
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 – 2020
11.2.1.3. Market Forecast, 2021 – 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 – 2020
11.2.1.5.1.2. Market
Forecast, 2021 – 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2020
11.2.1.5.2.2. Market
Forecast, 2021 – 2029
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2020
11.2.1.5.3.2. Market
Forecast, 2021 – 2029
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2020
11.2.1.5.4.2. Market
Forecast, 2021 – 2029
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 – 2020
11.2.1.5.5.2. Market
Forecast, 2021 – 2029
11.2.2. Pharmaceutical Manufacturing Companies
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 – 2020
11.2.2.3. Market Forecast, 2021 – 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 – 2020
11.2.2.5.1.2. Market
Forecast, 2021 – 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2020
11.2.2.5.2.2. Market
Forecast, 2021 – 2029
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2020
11.2.2.5.3.2. Market
Forecast, 2021 – 2029
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2020
11.2.2.5.4.2. Market
Forecast, 2021 – 2029
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 – 2020
11.2.2.5.5.2. Market
Forecast, 2021 – 2029
11.3. Key
Segment for Channeling Investments
11.3.1. By End Users
12. Global Equine Serum Market Analysis and Forecasts, 2021 –
2029
12.1. Overview
12.2. Global
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.2.1. Online
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 – 2020
12.2.1.3. Market Forecast, 2021 – 2029
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 – 2020
12.2.1.5.1.2. Market
Forecast, 2021 – 2029
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 – 2020
12.2.1.5.2.2. Market
Forecast, 2021 – 2029
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 – 2020
12.2.1.5.3.2. Market
Forecast, 2021 – 2029
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 – 2020
12.2.1.5.4.2. Market
Forecast, 2021 – 2029
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 – 2020
12.2.1.5.5.2. Market
Forecast, 2021 – 2029
12.2.2. Offline
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 – 2020
12.2.2.3. Market Forecast, 2021 – 2029
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 – 2020
12.2.2.5.1.2. Market
Forecast, 2021 – 2029
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 – 2020
12.2.2.5.2.2. Market
Forecast, 2021 – 2029
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 – 2020
12.2.2.5.3.2. Market
Forecast, 2021 – 2029
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 – 2020
12.2.2.5.4.2. Market
Forecast, 2021 – 2029
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 – 2020
12.2.2.5.5.2. Market
Forecast, 2021 – 2029
12.3. Key
Segment for Channeling Investments
12.3.1. By Distribution Channel
13. North America Equine Serum Market Analysis and Forecasts,
2020 - 2028
13.1. Overview
13.1.1. North America Equine Serum Market Revenue (US$ Mn)
13.2. North
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Formulation Type
13.2.1. Heat Inactivated
13.2.2. Non Heat Inactivated
13.2.3. Customized Formulations
13.2.4. Others
13.3. North
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Diagnostic Assay
13.3.2. Vaccine Production for Humans and Animals
13.3.3. Supplement in Bacteriological Media
13.3.4. Others
13.4. North
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Packaging Size
13.4.1. 100 ml
13.4.2. 500 ml
13.4.3. 1000 ml
13.4.4. Custom Packaging
13.4.5. Others
13.5. North
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Research Institutions
13.5.2. Pharmaceutical Manufacturing Companies
13.6. North
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.6.1. Online
13.6.2. Offline
13.7. North
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
13.7.1.1.1. Heat Inactivated
13.7.1.1.2. Non Heat Inactivated
13.7.1.1.3. Customized Formulations
13.7.1.1.4. Others
13.7.1.2. U.S Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.1.2.1. Diagnostic Assay
13.7.1.2.2. Vaccine Production for Humans and Animals
13.7.1.2.3. Supplement in Bacteriological Media
13.7.1.2.4. Others
13.7.1.3. U.S Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
13.7.1.3.1. 100 ml
13.7.1.3.2. 500 ml
13.7.1.3.3. 1000 ml
13.7.1.3.4. Custom Packaging
13.7.1.3.5. Others
13.7.1.4. U.S Equine Serum Market Revenue (US$ Mn) and Forecasts, By End
Users
13.7.1.4.1. Research Institutions
13.7.1.4.2. Pharmaceutical Manufacturing Companies
13.7.1.5. U.S Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.1.5.1. Online
13.7.1.5.2. Offline
13.7.2. Canada
13.7.2.1. Canada Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
13.7.2.1.1. Heat Inactivated
13.7.2.1.2. Non Heat Inactivated
13.7.2.1.3. Customized Formulations
13.7.2.1.4. Others
13.7.2.2. Canada Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.2.2.1. Diagnostic Assay
13.7.2.2.2. Vaccine Production for Humans and Animals
13.7.2.2.3. Supplement in Bacteriological Media
13.7.2.2.4. Others
13.7.2.3. Canada Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
13.7.2.3.1. 100 ml
13.7.2.3.2. 500 ml
13.7.2.3.3. 1000 ml
13.7.2.3.4. Custom Packaging
13.7.2.3.5. Others
13.7.2.4. Canada Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
13.7.2.4.1. Research Institutions
13.7.2.4.2. Pharmaceutical Manufacturing Companies
13.7.2.5. Canada Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.2.5.1. Online
13.7.2.5.2. Offline
13.7.3. Mexico
13.7.3.1. Mexico Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
13.7.3.1.1. Heat Inactivated
13.7.3.1.2. Non Heat Inactivated
13.7.3.1.3. Customized Formulations
13.7.3.1.4. Others
13.7.3.2. Mexico Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.3.2.1. Diagnostic Assay
13.7.3.2.2. Vaccine Production for Humans and Animals
13.7.3.2.3. Supplement in Bacteriological Media
13.7.3.2.4. Others
13.7.3.3. Mexico Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
13.7.3.3.1. 100 ml
13.7.3.3.2. 500 ml
13.7.3.3.3. 1000 ml
13.7.3.3.4. Custom Packaging
13.7.3.3.5. Others
13.7.3.4. Mexico Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
13.7.3.4.1. Research Institutions
13.7.3.4.2. Pharmaceutical Manufacturing Companies
13.7.3.5. Mexico Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.3.5.1. Online
13.7.3.5.2. Offline
13.7.4. Rest of North America
13.7.4.1. Rest of North America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
13.7.4.1.1. Heat Inactivated
13.7.4.1.2. Non Heat Inactivated
13.7.4.1.3. Customized Formulations
13.7.4.1.4. Others
13.7.4.2. Rest of North America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.4.2.1. Diagnostic Assay
13.7.4.2.2. Vaccine Production for Humans and Animals
13.7.4.2.3. Supplement in Bacteriological Media
13.7.4.2.4. Others
13.7.4.3. Rest of North America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
13.7.4.3.1. 100 ml
13.7.4.3.2. 500 ml
13.7.4.3.3. 1000 ml
13.7.4.3.4. Custom Packaging
13.7.4.3.5. Others
13.7.4.4. Rest of North America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
13.7.4.4.1. Research Institutions
13.7.4.4.2. Pharmaceutical Manufacturing Companies
13.7.4.5. Rest of North America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.7.4.5.1. Online
13.7.4.5.2. Offline
13.8. Key
Segment for Channeling Investments
13.8.1. By Country
13.8.2. By Formulation Type
13.8.3. By Application
13.8.4. By Packaging Size
13.8.5. By End Users
13.8.6. By Distribution Channel
14. Europe Equine Serum Market Analysis and Forecasts, 2020 -
2028
14.1. Overview
14.1.1. Europe Equine Serum Market Revenue (US$ Mn)
14.2. Europe
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Formulation Type
14.2.1. Heat Inactivated
14.2.2. Non Heat Inactivated
14.2.3. Customized Formulations
14.2.4. Others
14.3. Europe
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Diagnostic Assay
14.3.2. Vaccine Production for Humans and Animals
14.3.3. Supplement in Bacteriological Media
14.3.4. Others
14.4. Europe
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Packaging Size
14.4.1. 100 ml
14.4.2. 500 ml
14.4.3. 1000 ml
14.4.4. Custom Packaging
14.4.5. Others
14.5. Europe
Equine Serum Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Research Institutions
14.5.2. Pharmaceutical Manufacturing Companies
14.6. Europe
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.6.1. Online
14.6.2. Offline
14.7. Europe
Equine Serum Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
14.7.1.1.1. Heat Inactivated
14.7.1.1.2. Non Heat Inactivated
14.7.1.1.3. Customized Formulations
14.7.1.1.4. Others
14.7.1.2. France Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.1.2.1. Diagnostic Assay
14.7.1.2.2. Vaccine Production for Humans and Animals
14.7.1.2.3. Supplement in Bacteriological Media
14.7.1.2.4. Others
14.7.1.3. France Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.1.3.1. 100 ml
14.7.1.3.2. 500 ml
14.7.1.3.3. 1000 ml
14.7.1.3.4. Custom Packaging
14.7.1.3.5. Others
14.7.1.4. France Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
14.7.1.4.1. Research Institutions
14.7.1.4.2. Pharmaceutical Manufacturing Companies
14.7.1.5. France Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.1.5.1. Online
14.7.1.5.2. Offline
14.7.2. The UK
14.7.2.1. The UK Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
14.7.2.1.1. Heat Inactivated
14.7.2.1.2. Non Heat Inactivated
14.7.2.1.3. Customized Formulations
14.7.2.1.4. Others
14.7.2.2. The UK Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.2.2.1. Diagnostic Assay
14.7.2.2.2. Vaccine Production for Humans and Animals
14.7.2.2.3. Supplement in Bacteriological Media
14.7.2.2.4. Others
14.7.2.3. The UK Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.2.3.1. 100 ml
14.7.2.3.2. 500 ml
14.7.2.3.3. 1000 ml
14.7.2.3.4. Custom Packaging
14.7.2.3.5. Others
14.7.2.4. The UK Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
14.7.2.4.1. Research Institutions
14.7.2.4.2. Pharmaceutical Manufacturing Companies
14.7.2.5. The UK Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.2.5.1. Online
14.7.2.5.2. Offline
14.7.3. Spain
14.7.3.1. Spain Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
14.7.3.1.1. Heat Inactivated
14.7.3.1.2. Non Heat Inactivated
14.7.3.1.3. Customized Formulations
14.7.3.1.4. Others
14.7.3.2. Spain Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.3.2.1. Diagnostic Assay
14.7.3.2.2. Vaccine Production for Humans and Animals
14.7.3.2.3. Supplement in Bacteriological Media
14.7.3.2.4. Others
14.7.3.3. Spain Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.3.3.1. 100 ml
14.7.3.3.2. 500 ml
14.7.3.3.3. 1000 ml
14.7.3.3.4. Custom Packaging
14.7.3.3.5. Others
14.7.3.4. Spain Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
14.7.3.4.1. Research Institutions
14.7.3.4.2. Pharmaceutical Manufacturing Companies
14.7.3.5. Spain Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.3.5.1. Online
14.7.3.5.2. Offline
14.7.4. Germany
14.7.4.1. Germany Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
14.7.4.1.1. Heat Inactivated
14.7.4.1.2. Non Heat Inactivated
14.7.4.1.3. Customized Formulations
14.7.4.1.4. Others
14.7.4.2. Germany Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.4.2.1. Diagnostic Assay
14.7.4.2.2. Vaccine Production for Humans and Animals
14.7.4.2.3. Supplement in Bacteriological Media
14.7.4.2.4. Others
14.7.4.3. Germany Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.4.3.1. 100 ml
14.7.4.3.2. 500 ml
14.7.4.3.3. 1000 ml
14.7.4.3.4. Custom Packaging
14.7.4.3.5. Others
14.7.4.4. Germany Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
14.7.4.4.1. Research Institutions
14.7.4.4.2. Pharmaceutical Manufacturing Companies
14.7.4.5. Germany Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.4.5.1. Online
14.7.4.5.2. Offline
14.7.5. Italy
14.7.5.1. Italy Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
14.7.5.1.1. Heat Inactivated
14.7.5.1.2. Non Heat Inactivated
14.7.5.1.3. Customized Formulations
14.7.5.1.4. Others
14.7.5.2. Italy Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.5.2.1. Diagnostic Assay
14.7.5.2.2. Vaccine Production for Humans and Animals
14.7.5.2.3. Supplement in Bacteriological Media
14.7.5.2.4. Others
14.7.5.3. Italy Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
14.7.5.3.1. 100 ml
14.7.5.3.2. 500 ml
14.7.5.3.3. 1000 ml
14.7.5.3.4. Custom Packaging
14.7.5.3.5. Others
14.7.5.4. Italy Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
14.7.5.4.1. Research Institutions
14.7.5.4.2. Pharmaceutical Manufacturing Companies
14.7.5.5. Italy Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.5.5.1. Online
14.7.5.5.2. Offline
14.7.6. Nordic Countries
14.7.6.1. Nordic Countries Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
14.7.6.1.1. Heat Inactivated
14.7.6.1.2. Non Heat Inactivated
14.7.6.1.3. Customized Formulations
14.7.6.1.4. Others
14.7.6.2. Nordic Countries Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.6.2.1. Diagnostic Assay
14.7.6.2.2. Vaccine Production for Humans and Animals
14.7.6.2.3. Supplement in Bacteriological Media
14.7.6.2.4. Others
14.7.6.3. Nordic Countries Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
14.7.6.3.1. 100 ml
14.7.6.3.2. 500 ml
14.7.6.3.3. 1000 ml
14.7.6.3.4. Custom Packaging
14.7.6.3.5. Others
14.7.6.4. Nordic Countries Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.6.4.1. Research Institutions
14.7.6.4.2. Pharmaceutical Manufacturing Companies
14.7.6.5. Nordic Countries Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.7.6.5.1. Online
14.7.6.5.2. Offline
14.7.6.6. Nordic Countries Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux Union
14.7.7.1. Benelux Union Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
14.7.7.1.1. Heat Inactivated
14.7.7.1.2. Non Heat Inactivated
14.7.7.1.3. Customized Formulations
14.7.7.1.4. Others
14.7.7.2. Benelux Union Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.7.2.1. Diagnostic Assay
14.7.7.2.2. Vaccine Production for Humans and Animals
14.7.7.2.3. Supplement in Bacteriological Media
14.7.7.2.4. Others
14.7.7.3. Benelux Union Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
14.7.7.3.1. 100 ml
14.7.7.3.2. 500 ml
14.7.7.3.3. 1000 ml
14.7.7.3.4. Custom Packaging
14.7.7.3.5. Others
14.7.7.4. Benelux Union Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.7.4.1. Research Institutions
14.7.7.4.2. Pharmaceutical Manufacturing Companies
14.7.7.5. Benelux Union Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.7.7.5.1. Online
14.7.7.5.2. Offline
14.7.7.6. Benelux Union Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of Europe
14.7.8.1. Rest of Europe Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
14.7.8.1.1. Heat Inactivated
14.7.8.1.2. Non Heat Inactivated
14.7.8.1.3. Customized Formulations
14.7.8.1.4. Others
14.7.8.2. Rest of Europe Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.8.2.1. Diagnostic Assay
14.7.8.2.2. Vaccine Production for Humans and Animals
14.7.8.2.3. Supplement in Bacteriological Media
14.7.8.2.4. Others
14.7.8.3. Rest of Europe Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
14.7.8.3.1. 100 ml
14.7.8.3.2. 500 ml
14.7.8.3.3. 1000 ml
14.7.8.3.4. Custom Packaging
14.7.8.3.5. Others
14.7.8.4. Rest of Europe Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.8.4.1. Research Institutions
14.7.8.4.2. Pharmaceutical Manufacturing Companies
14.7.8.5. Rest of Europe Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.7.8.5.1. Online
14.7.8.5.2. Offline
14.8. Key
Segment for Channeling Investments
14.8.1. By Country
14.8.2. By Formulation Type
14.8.3. By Application
14.8.4. By Packaging Size
14.8.5. By End Users
14.8.6. By Distribution Channel
15. Asia Pacific Equine Serum Market Analysis and Forecasts, 2020
- 2028
15.1. Overview
15.1.1. Asia Pacific Equine Serum Market Revenue (US$ Mn)
15.2. Asia
Pacific Equine Serum Market Revenue (US$ Mn) and Forecasts, By Formulation Type
15.2.1. Heat Inactivated
15.2.2. Non Heat Inactivated
15.2.3. Customized Formulations
15.2.4. Others
15.3. Asia
Pacific Equine Serum Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Diagnostic Assay
15.3.2. Vaccine Production for Humans and Animals
15.3.3. Supplement in Bacteriological Media
15.3.4. Others
15.4. Asia
Pacific Equine Serum Market Revenue (US$ Mn) and Forecasts, By Packaging Size
15.4.1. 100 ml
15.4.2. 500 ml
15.4.3. 1000 ml
15.4.4. Custom Packaging
15.4.5. Others
15.5. Asia
Pacific Equine Serum Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Research Institutions
15.5.2. Pharmaceutical Manufacturing Companies
15.6. Asia
Pacific Equine Serum Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.6.1. Online
15.6.2. Offline
15.7. Asia
Pacific Equine Serum Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
15.7.1.1.1. Heat Inactivated
15.7.1.1.2. Non Heat Inactivated
15.7.1.1.3. Customized Formulations
15.7.1.1.4. Others
15.7.1.2. China Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.1.2.1. Diagnostic Assay
15.7.1.2.2. Vaccine Production for Humans and Animals
15.7.1.2.3. Supplement in Bacteriological Media
15.7.1.2.4. Others
15.7.1.3. China Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
15.7.1.3.1. 100 ml
15.7.1.3.2. 500 ml
15.7.1.3.3. 1000 ml
15.7.1.3.4. Custom Packaging
15.7.1.3.5. Others
15.7.1.4. China Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
15.7.1.4.1. Research Institutions
15.7.1.4.2. Pharmaceutical Manufacturing Companies
15.7.1.5. China Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.1.5.1. Online
15.7.1.5.2. Offline
15.7.2. Japan
15.7.2.1. Japan Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
15.7.2.1.1. Heat Inactivated
15.7.2.1.2. Non Heat Inactivated
15.7.2.1.3. Customized Formulations
15.7.2.1.4. Others
15.7.2.2. Japan Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.2.2.1. Diagnostic Assay
15.7.2.2.2. Vaccine Production for Humans and Animals
15.7.2.2.3. Supplement in Bacteriological Media
15.7.2.2.4. Others
15.7.2.3. Japan Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
15.7.2.3.1. 100 ml
15.7.2.3.2. 500 ml
15.7.2.3.3. 1000 ml
15.7.2.3.4. Custom Packaging
15.7.2.3.5. Others
15.7.2.4. Japan Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
15.7.2.4.1. Research Institutions
15.7.2.4.2. Pharmaceutical Manufacturing Companies
15.7.2.5. Japan Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.2.5.1. Online
15.7.2.5.2. Offline
15.7.3. India
15.7.3.1. India Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
15.7.3.1.1. Heat Inactivated
15.7.3.1.2. Non Heat Inactivated
15.7.3.1.3. Customized Formulations
15.7.3.1.4. Others
15.7.3.2. India Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.3.2.1. Diagnostic Assay
15.7.3.2.2. Vaccine Production for Humans and Animals
15.7.3.2.3. Supplement in Bacteriological Media
15.7.3.2.4. Others
15.7.3.3. India Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
15.7.3.3.1. 100 ml
15.7.3.3.2. 500 ml
15.7.3.3.3. 1000 ml
15.7.3.3.4. Custom Packaging
15.7.3.3.5. Others
15.7.3.4. India Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
15.7.3.4.1. Research Institutions
15.7.3.4.2. Pharmaceutical Manufacturing Companies
15.7.3.5. India Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.3.5.1. Online
15.7.3.5.2. Offline
15.7.4. New Zealand
15.7.4.1. New Zealand Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
15.7.4.1.1. Heat Inactivated
15.7.4.1.2. Non Heat Inactivated
15.7.4.1.3. Customized Formulations
15.7.4.1.4. Others
15.7.4.2. New Zealand Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.4.2.1. Diagnostic Assay
15.7.4.2.2. Vaccine Production for Humans and Animals
15.7.4.2.3. Supplement in Bacteriological Media
15.7.4.2.4. Others
15.7.4.3. New Zealand Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
15.7.4.3.1. 100 ml
15.7.4.3.2. 500 ml
15.7.4.3.3. 1000 ml
15.7.4.3.4. Custom Packaging
15.7.4.3.5. Others
15.7.4.4. New Zealand Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.4.4.1. Research Institutions
15.7.4.4.2. Pharmaceutical Manufacturing Companies
15.7.4.5. New Zealand Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.7.4.5.1. Online
15.7.4.5.2. Offline
15.7.5. Australia
15.7.5.1. Australia Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Formulation Type
15.7.5.1.1. Heat Inactivated
15.7.5.1.2. Non Heat Inactivated
15.7.5.1.3. Customized Formulations
15.7.5.1.4. Others
15.7.5.2. Australia Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Application
15.7.5.2.1. Diagnostic Assay
15.7.5.2.2. Vaccine Production for Humans and Animals
15.7.5.2.3. Supplement in Bacteriological Media
15.7.5.2.4. Others
15.7.5.3. Australia Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Packaging Size
15.7.5.3.1. 100 ml
15.7.5.3.2. 500 ml
15.7.5.3.3. 1000 ml
15.7.5.3.4. Custom Packaging
15.7.5.3.5. Others
15.7.5.4. Australia Equine Serum Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.5.4.1. Research Institutions
15.7.5.4.2. Pharmaceutical Manufacturing Companies
15.7.5.5. Australia Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.7.5.5.1. Online
15.7.5.5.2. Offline
15.7.6. South Korea
15.7.6.1. South Korea Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
15.7.6.1.1. Heat Inactivated
15.7.6.1.2. Non Heat Inactivated
15.7.6.1.3. Customized Formulations
15.7.6.1.4. Others
15.7.6.2. South Korea Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.6.2.1. Diagnostic Assay
15.7.6.2.2. Vaccine Production for Humans and Animals
15.7.6.2.3. Supplement in Bacteriological Media
15.7.6.2.4. Others
15.7.6.3. South Korea Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
15.7.6.3.1. 100 ml
15.7.6.3.2. 500 ml
15.7.6.3.3. 1000 ml
15.7.6.3.4. Custom Packaging
15.7.6.3.5. Others
15.7.6.4. South Korea Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.6.4.1. Research Institutions
15.7.6.4.2. Pharmaceutical Manufacturing Companies
15.7.6.5. South Korea Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.7.6.5.1. Online
15.7.6.5.2. Offline
15.7.7. Southeast Asia
15.7.7.1. Southeast Asia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
15.7.7.1.1. Heat Inactivated
15.7.7.1.2. Non Heat Inactivated
15.7.7.1.3. Customized Formulations
15.7.7.1.4. Others
15.7.7.2. Southeast Asia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.7.2.1. Diagnostic Assay
15.7.7.2.2. Vaccine Production for Humans and Animals
15.7.7.2.3. Supplement in Bacteriological Media
15.7.7.2.4. Others
15.7.7.3. Southeast Asia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
15.7.7.3.1. 100 ml
15.7.7.3.2. 500 ml
15.7.7.3.3. 1000 ml
15.7.7.3.4. Custom Packaging
15.7.7.3.5. Others
15.7.7.4. Southeast Asia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.7.4.1. Research Institutions
15.7.7.4.2. Pharmaceutical Manufacturing Companies
15.7.7.5. Southeast Asia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.7.7.5.1. Online
15.7.7.5.2. Offline
15.7.7.6. Southeast Asia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest of Southeast Asia
15.7.8. Rest of Asia Pacific
15.7.8.1. Rest of Asia Pacific Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
15.7.8.1.1. Heat Inactivated
15.7.8.1.2. Non Heat Inactivated
15.7.8.1.3. Customized Formulations
15.7.8.1.4. Others
15.7.8.2. Rest of Asia Pacific Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.8.2.1. Diagnostic Assay
15.7.8.2.2. Vaccine Production for Humans and Animals
15.7.8.2.3. Supplement in Bacteriological Media
15.7.8.2.4. Others
15.7.8.3. Rest of Asia Pacific Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
15.7.8.3.1. 100 ml
15.7.8.3.2. 500 ml
15.7.8.3.3. 1000 ml
15.7.8.3.4. Custom Packaging
15.7.8.3.5. Others
15.7.8.4. Rest of Asia Pacific Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.8.4.1. Research Institutions
15.7.8.4.2. Pharmaceutical Manufacturing Companies
15.7.8.5. Rest of Asia Pacific Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.7.8.5.1. Online
15.7.8.5.2. Offline
15.8. Key
Segment for Channeling Investments
15.8.1. By Country
15.8.2. By Formulation Type
15.8.3. By Application
15.8.4. By Packaging Size
15.8.5. By End Users
15.8.6. By Distribution Channel
16. Middle East and Africa Equine Serum Market Analysis and
Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Middle East and Africa Equine Serum Market Revenue (US$ Mn)
16.2. Middle
East and Africa Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
16.2.1. Heat Inactivated
16.2.2. Non Heat Inactivated
16.2.3. Customized Formulations
16.2.4. Others
16.3. Middle
East and Africa Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
16.3.1. Diagnostic Assay
16.3.2. Vaccine Production for Humans and Animals
16.3.3. Supplement in Bacteriological Media
16.3.4. Others
16.4. Middle
East and Africa Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
16.4.1. 100 ml
16.4.2. 500 ml
16.4.3. 1000 ml
16.4.4. Custom Packaging
16.4.5. Others
16.5. Middle
East and Africa Equine Serum Market Revenue (US$ Mn) and Forecasts, By End
Users
16.5.1. Research Institutions
16.5.2. Pharmaceutical Manufacturing Companies
16.6. Middle
East and Africa Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.6.1. Online
16.6.2. Offline
16.7. Middle
East and Africa Equine Serum Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi Arabia
16.7.1.1. Saudi Arabia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
16.7.1.1.1. Heat Inactivated
16.7.1.1.2. Non Heat Inactivated
16.7.1.1.3. Customized Formulations
16.7.1.1.4. Others
16.7.1.2. Saudi Arabia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.1.2.1. Diagnostic Assay
16.7.1.2.2. Vaccine Production for Humans and Animals
16.7.1.2.3. Supplement in Bacteriological Media
16.7.1.2.4. Others
16.7.1.3. Saudi Arabia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
16.7.1.3.1. 100 ml
16.7.1.3.2. 500 ml
16.7.1.3.3. 1000 ml
16.7.1.3.4. Custom Packaging
16.7.1.3.5. Others
16.7.1.4. Saudi Arabia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.1.4.1. Research Institutions
16.7.1.4.2. Pharmaceutical Manufacturing Companies
16.7.1.5. Saudi Arabia Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.7.1.5.1. Online
16.7.1.5.2. Offline
16.7.2. UAE
16.7.2.1. UAE Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
16.7.2.1.1. Heat Inactivated
16.7.2.1.2. Non Heat Inactivated
16.7.2.1.3. Customized Formulations
16.7.2.1.4. Others
16.7.2.2. UAE Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.2.2.1. Diagnostic Assay
16.7.2.2.2. Vaccine Production for Humans and Animals
16.7.2.2.3. Supplement in Bacteriological Media
16.7.2.2.4. Others
16.7.2.3. UAE Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
16.7.2.3.1. 100 ml
16.7.2.3.2. 500 ml
16.7.2.3.3. 1000 ml
16.7.2.3.4. Custom Packaging
16.7.2.3.5. Others
16.7.2.4. UAE Equine Serum Market Revenue (US$ Mn) and Forecasts, By End
Users
16.7.2.4.1. Research Institutions
16.7.2.4.2. Pharmaceutical Manufacturing Companies
16.7.2.5. UAE Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.2.5.1. Online
16.7.2.5.2. Offline
16.7.3. Egypt
16.7.3.1. Egypt Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
16.7.3.1.1. Heat Inactivated
16.7.3.1.2. Non Heat Inactivated
16.7.3.1.3. Customized Formulations
16.7.3.1.4. Others
16.7.3.2. Egypt Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.3.2.1. Diagnostic Assay
16.7.3.2.2. Vaccine Production for Humans and Animals
16.7.3.2.3. Supplement in Bacteriological Media
16.7.3.2.4. Others
16.7.3.3. Egypt Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
16.7.3.3.1. 100 ml
16.7.3.3.2. 500 ml
16.7.3.3.3. 1000 ml
16.7.3.3.4. Custom Packaging
16.7.3.3.5. Others
16.7.3.4. Egypt Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
16.7.3.4.1. Research Institutions
16.7.3.4.2. Pharmaceutical Manufacturing Companies
16.7.3.5. Egypt Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.3.5.1. Online
16.7.3.5.2. Offline
16.7.4. Kuwait
16.7.4.1. Kuwait Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
16.7.4.1.1. Heat Inactivated
16.7.4.1.2. Non Heat Inactivated
16.7.4.1.3. Customized Formulations
16.7.4.1.4. Others
16.7.4.2. Kuwait Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.4.2.1. Diagnostic Assay
16.7.4.2.2. Vaccine Production for Humans and Animals
16.7.4.2.3. Supplement in Bacteriological Media
16.7.4.2.4. Others
16.7.4.3. Kuwait Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
16.7.4.3.1. 100 ml
16.7.4.3.2. 500 ml
16.7.4.3.3. 1000 ml
16.7.4.3.4. Custom Packaging
16.7.4.3.5. Others
16.7.4.4. Kuwait Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
16.7.4.4.1. Research Institutions
16.7.4.4.2. Pharmaceutical Manufacturing Companies
16.7.4.5. Kuwait Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.4.5.1. Online
16.7.4.5.2. Offline
16.7.5. South Africa
16.7.5.1. South Africa Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
16.7.5.1.1. Heat Inactivated
16.7.5.1.2. Non Heat Inactivated
16.7.5.1.3. Customized Formulations
16.7.5.1.4. Others
16.7.5.2. South Africa Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.5.2.1. Diagnostic Assay
16.7.5.2.2. Vaccine Production for Humans and Animals
16.7.5.2.3. Supplement in Bacteriological Media
16.7.5.2.4. Others
16.7.5.3. South Africa Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
16.7.5.3.1. 100 ml
16.7.5.3.2. 500 ml
16.7.5.3.3. 1000 ml
16.7.5.3.4. Custom Packaging
16.7.5.3.5. Others
16.7.5.4. South Africa Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.5.4.1. Research Institutions
16.7.5.4.2. Pharmaceutical Manufacturing Companies
16.7.5.5. South Africa Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.7.5.5.1. Online
16.7.5.5.2. Offline
16.7.6. Rest of Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Equine Serum Market Revenue
(US$ Mn) and Forecasts, By Formulation Type
16.7.6.1.1. Heat Inactivated
16.7.6.1.2. Non Heat Inactivated
16.7.6.1.3. Customized Formulations
16.7.6.1.4. Others
16.7.6.2. Rest of Middle East & Africa Equine Serum Market Revenue
(US$ Mn) and Forecasts, By Application
16.7.6.2.1. Diagnostic Assay
16.7.6.2.2. Vaccine Production for Humans and Animals
16.7.6.2.3. Supplement in Bacteriological Media
16.7.6.2.4. Others
16.7.6.3. Rest of Middle East & Africa Equine Serum Market Revenue
(US$ Mn) and Forecasts, By Packaging Size
16.7.6.3.1. 100 ml
16.7.6.3.2. 500 ml
16.7.6.3.3. 1000 ml
16.7.6.3.4. Custom Packaging
16.7.6.3.5. Others
16.7.6.4. Rest of Middle East & Africa Equine Serum Market Revenue
(US$ Mn) and Forecasts, By End Users
16.7.6.4.1. Research Institutions
16.7.6.4.2. Pharmaceutical Manufacturing Companies
16.7.6.5. Rest of Middle East & Africa Equine Serum Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
16.7.6.5.1. Online
16.7.6.5.2. Offline
16.8. Key
Segment for Channeling Investments
16.8.1. By Country
16.8.2. By Formulation Type
16.8.3. By Application
16.8.4. By Packaging Size
16.8.5. By End Users
16.8.6. By Distribution Channel
17. Latin America Equine Serum Market Analysis and Forecasts,
2020 - 2028
17.1. Overview
17.1.1. Latin America Equine Serum Market Revenue (US$ Mn)
17.2. Latin
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Formulation Type
17.2.1. Heat Inactivated
17.2.2. Non Heat Inactivated
17.2.3. Customized Formulations
17.2.4. Others
17.3. Latin
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Application
17.3.1. Diagnostic Assay
17.3.2. Vaccine Production for Humans and Animals
17.3.3. Supplement in Bacteriological Media
17.3.4. Others
17.4. Latin
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Packaging Size
17.4.1. 100 ml
17.4.2. 500 ml
17.4.3. 1000 ml
17.4.4. Custom Packaging
17.4.5. Others
17.5. Latin
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By End Users
17.5.1. Research Institutions
17.5.2. Pharmaceutical Manufacturing Companies
17.6. Latin
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.6.1. Online
17.6.2. Offline
17.7. Latin
America Equine Serum Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Formulation Type
17.7.1.1.1. Heat Inactivated
17.7.1.1.2. Non Heat Inactivated
17.7.1.1.3. Customized Formulations
17.7.1.1.4. Others
17.7.1.2. Brazil Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.1.2.1. Diagnostic Assay
17.7.1.2.2. Vaccine Production for Humans and Animals
17.7.1.2.3. Supplement in Bacteriological Media
17.7.1.2.4. Others
17.7.1.3. Brazil Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Packaging Size
17.7.1.3.1. 100 ml
17.7.1.3.2. 500 ml
17.7.1.3.3. 1000 ml
17.7.1.3.4. Custom Packaging
17.7.1.3.5. Others
17.7.1.4. Brazil Equine Serum Market Revenue (US$ Mn) and Forecasts, By
End Users
17.7.1.4.1. Research Institutions
17.7.1.4.2. Pharmaceutical Manufacturing Companies
17.7.1.5. Brazil Equine Serum Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.1.5.1. Online
17.7.1.5.2. Offline
17.7.2. Argentina
17.7.2.1. Argentina Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Formulation Type
17.7.2.1.1. Heat Inactivated
17.7.2.1.2. Non Heat Inactivated
17.7.2.1.3. Customized Formulations
17.7.2.1.4. Others
17.7.2.2. Argentina Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Application
17.7.2.2.1. Diagnostic Assay
17.7.2.2.2. Vaccine Production for Humans and Animals
17.7.2.2.3. Supplement in Bacteriological Media
17.7.2.2.4. Others
17.7.2.3. Argentina Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Packaging Size
17.7.2.3.1. 100 ml
17.7.2.3.2. 500 ml
17.7.2.3.3. 1000 ml
17.7.2.3.4. Custom Packaging
17.7.2.3.5. Others
17.7.2.4. Argentina Equine Serum Market Revenue (US$ Mn) and Forecasts,
By End Users
17.7.2.4.1. Research Institutions
17.7.2.4.2. Pharmaceutical Manufacturing Companies
17.7.2.5. Argentina Equine Serum Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
17.7.2.5.1. Online
17.7.2.5.2. Offline
17.7.3. Rest of Latin America
17.7.3.1. Rest of Latin America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Formulation Type
17.7.3.1.1. Heat Inactivated
17.7.3.1.2. Non Heat Inactivated
17.7.3.1.3. Customized Formulations
17.7.3.1.4. Others
17.7.3.2. Rest of Latin America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.3.2.1. Diagnostic Assay
17.7.3.2.2. Vaccine Production for Humans and Animals
17.7.3.2.3. Supplement in Bacteriological Media
17.7.3.2.4. Others
17.7.3.3. Rest of Latin America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Packaging Size
17.7.3.3.1. 100 ml
17.7.3.3.2. 500 ml
17.7.3.3.3. 1000 ml
17.7.3.3.4. Custom Packaging
17.7.3.3.5. Others
17.7.3.4. Rest of Latin America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By End Users
17.7.3.4.1. Research Institutions
17.7.3.4.2. Pharmaceutical Manufacturing Companies
17.7.3.5. Rest of Latin America Equine Serum Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.7.3.5.1. Online
17.7.3.5.2. Offline
17.8. Key
Segment for Channeling Investments
17.8.1. By Country
17.8.2. By Formulation Type
17.8.3. By Application
17.8.4. By Packaging Size
17.8.5. By End Users
17.8.6. By Distribution Channel
18. Competitive Benchmarking
18.1. Market
Share Analysis, 2020
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers and Acquisitions
18.2.2. Product Launches
18.2.3. Investments Trends
18.2.4. R&D Initiatives
19. Player Profiles
19.1. Abcam
plc.
19.1.1. Company Details
19.1.2. Company Overview
19.1.3. Product Offerings
19.1.4. Key Developments
19.1.5. Financial Analysis
19.1.6. SWOT Analysis
19.1.7. Business Strategies
19.2. Biochemed
Services.
19.2.1. Company Details
19.2.2. Company Overview
19.2.3. Product Offerings
19.2.4. Key Developments
19.2.5. Financial Analysis
19.2.6. SWOT Analysis
19.2.7. Business Strategies
19.3. Biologos
19.3.1. Company Details
19.3.2. Company Overview
19.3.3. Product Offerings
19.3.4. Key Developments
19.3.5. Financial Analysis
19.3.6. SWOT Analysis
19.3.7. Business Strategies
19.4. Jackson
ImmunoResearch Inc.
19.4.1. Company Details
19.4.2. Company Overview
19.4.3. Product Offerings
19.4.4. Key Developments
19.4.5. Financial Analysis
19.4.6. SWOT Analysis
19.4.7. Business Strategies
19.5. Merck
KGaA
19.5.1. Company Details
19.5.2. Company Overview
19.5.3. Product Offerings
19.5.4. Key Developments
19.5.5. Financial Analysis
19.5.6. SWOT Analysis
19.5.7. Business Strategies
19.6. MP
BIOMEDICALS
19.6.1. Company Details
19.6.2. Company Overview
19.6.3. Product Offerings
19.6.4. Key Developments
19.6.5. Financial Analysis
19.6.6. SWOT Analysis
19.6.7. Business Strategies
19.7. Rocky
Mountain Biologicals
19.7.1. Company Details
19.7.2. Company Overview
19.7.3. Product Offerings
19.7.4. Key Developments
19.7.5. Financial Analysis
19.7.6. SWOT Analysis
19.7.7. Business Strategies
19.8. TCS
Biosciences Ltd.
19.8.1. Company Details
19.8.2. Company Overview
19.8.3. Product Offerings
19.8.4. Key Developments
19.8.5. Financial Analysis
19.8.6. SWOT Analysis
19.8.7. Business Strategies
19.9. Thermo
Fisher Scientific Inc.
19.9.1. Company Details
19.9.2. Company Overview
19.9.3. Product Offerings
19.9.4. Key Developments
19.9.5. Financial Analysis
19.9.6. SWOT Analysis
19.9.7. Business Strategies
19.10. Other Market Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
